News
A new study co-authored by BirdLife’s Chief Scientist Dr Stuart Butchart and published in Nature Reviews Biodiversity reveals ...
Unlisted shares of Crizac are trading at Rs 287 against its IPO price of Rs 245, which is nearly 17% GMP, indicating mild ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results